Kevin Barvian

Kevin Barvian is a highly experienced scientist in the field of medicinal chemistry, currently serving as Senior Scientist 1 at Blueprint Medicines since July 2019. Prior experience includes roles as Scientist II at Blueprint Medicines, Research Scientist III at AMRI from October 2012 to July 2019, and Scientist in Medicinal Chemistry at AstraZeneca from September 2008 to August 2012, where notable contributions included designing and evaluating novel compounds. Kevin's career began at GlaxoSmithKline, where tenure spanned from January 1999 to August 2008, culminating in a promotion to Senior Scientist and involvement in programs targeting diabetes and obesity. Educational credentials include a Master of Science in Organic Chemistry from Indiana University Bloomington and a Bachelor of Science in Chemistry from Canisius University.